-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H7hjYjkNgcfhqMLlOIz6//718xUcvYHfsiIVh0l/mGYYhcJ17vVmvcJCHL7ACK6m f3rZry3erNQBwQ6XWFyyLA== 0001247741-05-000038.txt : 20050805 0001247741-05-000038.hdr.sgml : 20050805 20050805150958 ACCESSION NUMBER: 0001247741-05-000038 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050728 FILED AS OF DATE: 20050805 DATE AS OF CHANGE: 20050805 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 BUSINESS PHONE: 8585507500 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROUCH TAYLOR CENTRAL INDEX KEY: 0001197086 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20720 FILM NUMBER: 051002518 MAIL ADDRESS: STREET 1: 9640 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 3 1 edgardoc.xml PRIMARY DOCUMENT X0202 3 2005-07-28 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001197086 CROUCH TAYLOR 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 0 1 0 0 Sr. V-P, Ops & Pres. Int'l Employee Stock Option (right to buy) 5.84 2005-11-30 2015-05-31 Common Stock 120000 D Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 5/31/05. Table I, Col. 2 - Non-Derivative Securities Beneficially Owned - NO SECURITIES OWNED By: Barbara J. Olson For: Taylor J. Crouch 2005-08-05 EX-24 2 poatjc.txt EDGAR SUPPORTING DOCUMENT POWER OF ATTORNEY SEC FORMS 3, 4 and 5 The undersigned, Taylor J. Crouch, hereby appoints and designates each of Warner R. Broaddus, Paul V. Maier and Barbara J. Olson his/her attorney-in-fact, signing singly, to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Ligand Pharmaceuticals Incorporated. Any previous authority to act on the undersigned's behalf in connection with such execution and filing of Forms 3, 4 and 5 is hereby revoked and the authority of Warner R. Broaddus, Paul V. Maier and Barbara J. Olson under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4 and 5 with regard to the undersigned's ownership of or transactions in securities of Ligand Pharmaceuticals Incorporated, unless earlier revoked in writing. The undersigned acknowledges that neither Warner R. Broaddus, Paul V. Maier nor Barbara J. Olson is assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Date: July 28, 2005 /s/ Taylor J. Crouch Taylor J. Crouch -----END PRIVACY-ENHANCED MESSAGE-----